Pancreatic Cancer Research

ResearcherNewLink Genetics (United States)No recent work listed

Gabriela R. Rossi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0003-4526-7278; OpenAlex author ID A5044707124. Sources: OpenAlex.

Their work

Papers
6 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers

Papers 6

  1. Advanced glycation end product (AGE) targeting antibody SIWA318H is efficacious in preclinical models for pancreatic cancer. Co-author DOI 10.1038/s41598-023-44211-6↗
  2. Treatment Response in First-Line Metastatic Pancreatic Ductal Adenocarcinoma Is Stratified By a Composite Index of Tumor Proliferation and CD8 T-Cell Infiltrat… Co-author DOI 10.1158/1078-0432.ccr-23-0535↗
  3. A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable … Co-author DOI 10.1097/sla.0000000000004669↗
  4. Pancreatic cancer: Update on immunotherapies and algenpantucel-L. Co-author DOI 10.1080/21645515.2015.1093264↗
  5. Algenpantucel-L immunotherapy in pancreatic adenocarcinoma. First author DOI 10.2217/imt.15.113↗
  6. Immunotherapy updates in pancreatic cancer: are we there yet? First author DOI 10.1177/1758834012462463↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew L. Coveler · 3 shared papers, 2016–2022 · strength 0.26
  2. Serina Ng · 1 shared paper, 2023 · strength 0.18
  3. Haiyong Han · 1 shared paper, 2023 · strength 0.18
  4. Daniel D. Von Hoff · 1 shared paper, 2023 · strength 0.18
  5. Jae Woo Lee · 1 shared paper, 2023 · strength 0.16
  6. Joey H. Li · 1 shared paper, 2023 · strength 0.16
  7. Nathan Bahary · 1 shared paper, 2023 · strength 0.16
  8. Andrea Wang‐Gillam · 1 shared paper, 2023 · strength 0.16
  9. Ignacio Garrido‐Laguna · 1 shared paper, 2023 · strength 0.16
  10. Gregory Lawrence Beatty · 1 shared paper, 2023 · strength 0.16
  11. Elena Gabriela Chiorean · 2 shared papers, 2016 · strength 0.15
  12. Hassan A. Hatoum · 1 shared paper, 2022 · strength 0.12
  13. Noelle K. LoConte · 1 shared paper, 2022 · strength 0.12
  14. Gina M. Vaccaro · 1 shared paper, 2022 · strength 0.12
  15. Nicholas N. Nissen · 1 shared paper, 2022 · strength 0.12
  16. Daniel Brock Hewitt · 1 shared paper, 2022 · strength 0.12
  17. Thomas J. George · 1 shared paper, 2022 · strength 0.12
  18. Harish Lavu · 1 shared paper, 2022 · strength 0.12
  19. Benjamin Musher · 1 shared paper, 2022 · strength 0.12
  20. Charles J. Yeo · 1 shared paper, 2022 · strength 0.12
  21. Kinsey Ann McCormick · 1 shared paper, 2016 · strength 0.07
  22. Krishna Soujanya Gunturu · 1 shared paper, 2013 · strength 0.06
  23. Muhammad Saif Wasif · 1 shared paper, 2013 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.